Loading...
XJPX3341
Market cap260mUSD
Jan 17, Last price  
1,365.00JPY
1D
-0.94%
1Q
-6.31%
Jan 2017
-37.46%
Name

Nihon Chouzai Co Ltd

Chart & Performance

D1W1MN
XJPX:3341 chart
P/E
15.97
P/S
0.12
EPS
85.46
Div Yield, %
1.83%
Shrs. gr., 5y
-0.80%
Rev. gr., 5y
6.73%
Revenues
340.31b
+8.61%
51,869,497,00059,026,996,00065,788,804,00079,801,180,00085,891,964,00098,260,133,000112,128,909,000130,041,000,000139,466,000,000165,347,000,000181,844,000,000219,239,000,000223,468,000,000241,274,000,000245,687,000,000268,520,000,000278,951,000,000299,392,000,000313,318,000,000340,310,000,000
Net income
2.55b
-42.73%
1,313,869,0001,333,442,000327,176,000399,928,000420,815,0001,404,336,0001,821,152,0002,085,000,000184,000,0001,901,000,0002,778,000,0006,329,000,0004,638,000,0006,104,000,0003,790,000,0006,697,000,0003,538,000,0003,705,000,0004,458,000,0002,553,000,000
CFO
20.42b
+171.12%
3,355,594,0002,838,904,0001,785,228,0002,943,119,000852,276,0003,833,917,0006,723,709,0007,127,000,0002,885,000,0006,243,000,0005,831,000,00019,327,000,000-940,000,00023,141,000,00013,572,000,00013,192,000,00011,213,000,00019,411,000,0007,532,000,00020,421,000,000
Dividend
Mar 28, 20250 JPY/sh

Profile

Nihon Chouzai Co., Ltd. engages in the management of health insurance dispensing chain pharmacies in Japan. The company also manufactures and sells generic drugs to medical institutions and other pharmacies. In addition, it offers temporary staffing services for pharmacist; and employment services for physicians and registered sales personnel, and other healthcare professionals. Further, the company provides studies and research services for pharmaceutical companies and organizations; information and consulting services for industries associated with pharmaceuticals and healthcare; and other services. As of March 31, 2022, it had 697 stores. The company was incorporated in 1980 and is headquartered in Tokyo, Japan.
URL
https://www.nicho.co.jp/
IPO date
Sep 17, 2004
Employees
5,689
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑032015‑03
Income
Revenues
340,310,000
8.61%
313,318,000
4.65%
299,392,000
7.33%
Cost of revenue
333,931,000
288,577,000
276,776,000
Unusual Expense (Income)
NOPBT
6,379,000
24,741,000
22,616,000
NOPBT Margin
1.87%
7.90%
7.55%
Operating Taxes
2,584,000
3,384,000
2,511,000
Tax Rate
40.51%
13.68%
11.10%
NOPAT
3,795,000
21,357,000
20,105,000
Net income
2,553,000
-42.73%
4,458,000
20.32%
3,705,000
4.72%
Dividends
(749,000)
(749,000)
(749,000)
Dividend yield
1.58%
2.16%
1.88%
Proceeds from repurchase of equity
14,255,000
BB yield
-41.19%
Debt
Debt current
11,602,000
12,533,000
13,514,000
Long-term debt
44,705,000
46,689,000
43,933,000
Deferred revenue
(577,000)
Other long-term liabilities
8,557,000
6,171,000
4,288,000
Net debt
25,387,000
25,072,000
22,193,000
Cash flow
Cash from operating activities
20,421,000
7,532,000
19,411,000
CAPEX
(10,460,000)
(7,755,000)
(7,709,000)
Cash from investing activities
(13,726,000)
(10,018,000)
(9,313,000)
Cash from financing activities
(4,430,000)
713,000
(17,448,000)
FCF
13,961,000
23,583,000
12,070,000
Balance
Cash
26,034,000
23,770,000
25,543,000
Long term investments
4,886,000
10,380,000
9,711,000
Excess cash
13,904,500
18,484,100
20,284,400
Stockholders' equity
51,021,000
105,652,000
98,336,000
Invested Capital
107,926,500
99,655,900
90,674,600
ROIC
3.66%
22.44%
21.43%
ROCE
5.24%
20.94%
20.28%
EV
Common stock shares outstanding
29,917
29,940
29,987
Price
1,584.00
37.02%
1,156.00
-13.08%
1,330.00
-25.49%
Market cap
47,387,791
36.92%
34,611,093
-13.22%
39,882,710
-25.49%
EV
72,774,791
116,178,093
114,961,710
EBITDA
15,542,000
33,433,000
30,999,000
EV/EBITDA
4.68
3.47
3.71
Interest
355,000
266,000
295,000
Interest/NOPBT
5.57%
1.08%
1.30%